Effect of Different Doses of Dexmedetomidine on Cerebral Oxygen Saturation and Postoperative Anxiety in Elderly Patients
Launched by THE FIRST HOSPITAL OF QINHUANGDAO · Dec 6, 2022
Trial Information
Current as of January 14, 2025
Completed
Keywords
ClinConnect Summary
A total of 105 patients who were admitted to The First Hospital of Qinhuangdao for laparoscopic surgery and divided into control group (group C), dexmedetomidine doses of 0.2 μg/kg (group D1), dexmedetomidine doses of 0.5 μg/kg (group D2).
105 patients were randomized equally into 3 groups. 35 cases in each group. Group C received general anesthesia without dexmedetomidine, groups D1 received general anesthesia with intravenous pump of 0. 2μg/kg/h dexmedetomidine, groups D2 received general anesthesia with intravenous pump of 0. 5μg/kg/h dexmedetomidine.SBP(Systolic Blood Pressure),DP(Dias...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 65 years or older who underwent elective laparoscopic surgery under general anesthesia
- • BMI less than 30 kg/m2
- • American Society of Anesthesiologists (ASA) grades I-III
- • The score of Mini Mental state examination≥24
- Exclusion Criteria:
- • Patients with heart, lung and other vital organ disorders
- • The score of Mini Mental state examination≤23
- • Preoperative psychiatric disorders or long-term use of drugs affecting the psychiatric system
- • Have severe visual, hearing, speech impairment or other inability to communicate with the visitor
- • Refuse to sign informed consent
- • known preoperative left ventricular ejection fraction less than 30%, sick sinus syndrome, severe sinus bradycardia (\<50 beats per min \[bpm\]), or second-degree or greater atrioventricular block without pacemaker
Trial Officials
Shujuan Liang, Master
Study Director
The First hosptial of Qinhuangdao
Hua Zhou, Master
Study Chair
The First hosptial of Qinhuangdao
About The First Hospital Of Qinhuangdao
The First Hospital of Qinhuangdao is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Renowned for its comprehensive range of services and state-of-the-art facilities, the hospital actively engages in clinical trials to explore new therapeutic interventions and improve patient outcomes. With a multidisciplinary team of experienced healthcare professionals, the First Hospital of Qinhuangdao is committed to upholding the highest standards of ethical research practices while fostering collaboration with local and international partners in the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Qinhuangdao, Hebei, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials